Ilya G. Kondratov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ilya G. Kondratov has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Oleg B. Ogarkov
Scientific centre for Family Health and Human Reproduction Problems
15 shared publications - Svetlana N. Zhdanova
Scientific centre for Family Health and Human Reproduction Problems
12 shared publications - Elizaveta A. Orlova
Scientific centre for Family Health and Human Reproduction Problems
6 shared publications - Viacheslav V. Sinkov
Scientific centre for Family Health and Human Reproduction Problems
6 shared publications - Lyubov Ilijinichna Kolesnikova
Scientific centre for Family Health and Human Reproduction Problems
5 shared publications - Lyubov Vladimirovna Rychkova
Scientific centre for Family Health and Human Reproduction Problems
5 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 71 (7-8) , 43-49
Mycobacterium tuberculosis Strains from Eastern Siberia Resistant to Bedaquiline and Linezolid: Identification of Novel Mutations
Background . The spread of resistance to bedaquiline and linezolid is a global public health issue across all countries. Investigating the molecular mechanisms underlying this resistance is crucial for curbing the spread of extensively drug-resistant (XDR) tuberculosis. The aim of the study was to identify mutations associated with resistance to bedaquiline and linezolid and to determine the genotypes of 26 Mycobacterium tuberculosis strains circulating in the Irkutsk Region and Yakutia in 2024–2025. Materials and methods . From a collection of 183 strain DNA samples, 26 strains exhibiting phenotypic resistance to bedaquiline and/or linezolid were selected. Sanger sequencing identified mutations listed in the WHO catalog. Additionally, SNP and indel analysis was performed using the previously developed BSATool software. Results. Phenotypically, the isolates were resistant to bedaquiline (16) and linezolid (14); 3 were pre-XDR and 15 were XDR, while the remainder were monoor poly-resistant. Four strains were resistant to both bedaquiline and linezolid. Among the 16 bedaquiline-resistant strains, five had loss-of-function (LoF) mutations, while the other nine carried mutations of uncertain significance. Eleven new mutations were identified, ten of which were conclusively classified as LoF mutations. For two bedaquiline-resistant strains where no SNPs were detected upon amplification of the Rv0678 gene, a significant increase in amplicon size was observed. Further analysis demonstrated that the bedaquiline resistance was caused by the insertion of the IS6110 mobile element at positions 179 and 370 of the Rv0678 gene. The strains belonged to different L2.2 subtypes: B0/W148 and CAO. Conclusion . The widespread use of bedaquiline and linezolid in the treatment of tuberculosis over the past 5 years in the study areas has provided selective advantages for strains implementing various molecular mechanisms of resistance to these drugs. When using molecular tests aimed at determining drug resistance, it is necessary to pay attention to a wide range of changes in the genome of the tuberculosis pathogen, including major genomic rearrangements.
- 11 November 2026
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 71 (7-8) , 43-49
Open AccessMycobacterium tuberculosis Strains from Eastern Siberia Resistant to Bedaquiline and Linezolid: Identification of Novel Mutations
Background . The spread of resistance to bedaquiline and linezolid is a global public health issue across all countries. Investigating the molecular mechanisms underlying this resistance is crucial for curbing the spread of extensively drug-resistant (XDR) tuberculosis. The aim of the study was to identify mutations associated with resistance to bedaquiline and linezolid and to determine the genotypes of 26 Mycobacterium tuberculosis strains circulating in the Irkutsk Region and Yakutia in 2024–2025. Materials and methods . From a collection of 183 strain DNA samples, 26 strains exhibiting phenotypic resistance to bedaquiline and/or linezolid were selected. Sanger sequencing identified mutations listed in the WHO catalog. Additionally, SNP and indel analysis was performed using the previously developed BSATool software. Results. Phenotypically, the isolates were resistant to bedaquiline (16) and linezolid (14); 3 were pre-XDR and 15 were XDR, while the remainder were monoor poly-resistant. Four strains were resistant to both bedaquiline and linezolid. Among the 16 bedaquiline-resistant strains, five had loss-of-function (LoF) mutations, while the other nine carried mutations of uncertain significance. Eleven new mutations were identified, ten of which were conclusively classified as LoF mutations. For two bedaquiline-resistant strains where no SNPs were detected upon amplification of the Rv0678 gene, a significant increase in amplicon size was observed. Further analysis demonstrated that the bedaquiline resistance was caused by the insertion of the IS6110 mobile element at positions 179 and 370 of the Rv0678 gene. The strains belonged to different L2.2 subtypes: B0/W148 and CAO. Conclusion . The widespread use of bedaquiline and linezolid in the treatment of tuberculosis over the past 5 years in the study areas has provided selective advantages for strains implementing various molecular mechanisms of resistance to these drugs. When using molecular tests aimed at determining drug resistance, it is necessary to pay attention to a wide range of changes in the genome of the tuberculosis pathogen, including major genomic rearrangements.
- Open Access
- 17 October 2026
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (4) , 177-189
Species diversity of nontuberculous mycobacteria isolated from patients in Irkutsk Region (a retrospective study)
Background. The Irkutsk Region remains a region with a high burden of multidrug-resistant tuberculosis and a challenging epidemiological situation regarding HIV infection. For immunocompromised individuals, the spread of nontuberculous mycobacteria (NTMB) poses a significant threat, as they cause pulmonary mycobacteriosis – a condition that mimics tuberculosis but requires differential diagnosis and distinct treatment approaches. Regional studies on NTMB prevalence remain limited. Given the low resolution of standard microbiological techniques, the search for molecular targets for NTMB species identification is essential. Aim. To evaluate the species diversity of NTMB isolated from patients with suspected pulmonary tuberculosis and mycobacteriosis in the Irkutsk Region. Materials and methods. A retrospective analysis was performed on NTMB strains obtained from 63 patients treated at the Irkutsk Regional Clinical Tuberculosis Hospital between 2018 and 2024. Species identification was performed for 50 isolates using sequencing of the 23S rRNA and groEL2 genes fragments, followed by phylogenetic analysis. Results. Representatives of the Mycobacterium avium complex (MAC) dominate among the studied strains (65.9%), including M. avium (53.7%) and M. intracellulare (12.2%). Joint analysis of the 23S rRNA and groEL2 gene fragments ensured the differentiation of species within the MAC, as well as the identification of a wide range of slowly and rapidly growing NTMB (M. paragordonae, M. abscessus, M. fortuitum, M. holsaticum, and M. farcinogenes/M. senegalense) and non-mycobacterial pathogens (Nocardia farcinica, Streptococcus oralis, Staphylococcus epidermidis, Actinomadura sp.). Conclusion. The taxonomic spectrum of NTMB isolated in the Irkutsk Region was characterized over time. Sequencing of the 23S rRNA and groEL2 genes allows overcoming the challenge of NTMB identification.
- 17 October 2026
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 11 (4) , 177-189
Open AccessSpecies diversity of nontuberculous mycobacteria isolated from patients in Irkutsk Region (a retrospective study)
Background. The Irkutsk Region remains a region with a high burden of multidrug-resistant tuberculosis and a challenging epidemiological situation regarding HIV infection. For immunocompromised individuals, the spread of nontuberculous mycobacteria (NTMB) poses a significant threat, as they cause pulmonary mycobacteriosis – a condition that mimics tuberculosis but requires differential diagnosis and distinct treatment approaches. Regional studies on NTMB prevalence remain limited. Given the low resolution of standard microbiological techniques, the search for molecular targets for NTMB species identification is essential. Aim. To evaluate the species diversity of NTMB isolated from patients with suspected pulmonary tuberculosis and mycobacteriosis in the Irkutsk Region. Materials and methods. A retrospective analysis was performed on NTMB strains obtained from 63 patients treated at the Irkutsk Regional Clinical Tuberculosis Hospital between 2018 and 2024. Species identification was performed for 50 isolates using sequencing of the 23S rRNA and groEL2 genes fragments, followed by phylogenetic analysis. Results. Representatives of the Mycobacterium avium complex (MAC) dominate among the studied strains (65.9%), including M. avium (53.7%) and M. intracellulare (12.2%). Joint analysis of the 23S rRNA and groEL2 gene fragments ensured the differentiation of species within the MAC, as well as the identification of a wide range of slowly and rapidly growing NTMB (M. paragordonae, M. abscessus, M. fortuitum, M. holsaticum, and M. farcinogenes/M. senegalense) and non-mycobacterial pathogens (Nocardia farcinica, Streptococcus oralis, Staphylococcus epidermidis, Actinomadura sp.). Conclusion. The taxonomic spectrum of NTMB isolated in the Irkutsk Region was characterized over time. Sequencing of the 23S rRNA and groEL2 genes allows overcoming the challenge of NTMB identification.
- Open Access
- 10 March 2026
- Published by Irkutsk State Medical University in Baikal Medical Journal
- Vol. 5 (1) , 72-79
VALIDATION OF A REAL-TIME PCR ASSAY FOR THE DETECTION OF THE SINGLE NUCLEOTIDE POLYMORPHISM RS1495741 IN THE HUMAN NAT2 GENE ASSOCIATED WITH XENOBIOTIC ACETYLATION
Relevance. According to polymorphisms in the N-acetyltransferase 2 gene, two main acetylation types are distinguished: rapid and slow. The frequency of adverse drug reactions varies depending on the rate of metabolism. In particular, the incidence of neuro- and hepatotoxic effects of isoniazid is associated with genotype, with slow acetylators having a higher risk of adverse reactions. Aim: To design and compare a reagent kit developed by the authors for detecting polymorphisms in the human N-acetyltransferase 2 gene using real-time Polymerase chain reaction, aimed at determining the type of xenobiotic acetylation in humans. Materials and Methods. Based on Eurasian Patent No. 042541, a laboratory prototype of a medical diagnostic reagent kit was developed. The kit included a real-time Polymerase chain reaction mixture, forward and reverse primers specific to the N-acetyltransferase 2 gene, and probes for detecting the rs1495741 polymorphism labeled with FAM and R6G fluorophores at the 5'-end and BHQ2 RTQ1 quenchers with closed nucleotides. Positive controls were constructed as circular plasmids pJet1.2/blunt containing the N-acetyltransferase 2 gene with rs1495741A and rs1495741G alleles. Using the developed kit, 37 Deoxyribonucleic acid samples obtained from healthy individuals were analyzed and compared with the reference method. Analytical sensitivity, diagnostic sensitivity, diagnostic specificity, precision, and reproducibility were assessed to validate the method. Results. Validation of the reagent kit for real-time Polymerase chain reaction determination of the xenobiotic acetylation type in humans was performed. The analytical sensitivity of the test, determined by titration of the positive control, was 0.1 ng/µL Deoxyribonucleic acid; diagnostic sensitivity was 0.94, and diagnostic specificity was 1. Other validation parameters met the established acceptability criteria, confirming adequate intra-laboratory precision and inter-laboratory reproducibility. Conclusion. Compared with the reference method, the proposed approach is less labor-intensive, time-saving, and more cost-effective, while maintaining comparable sensitivity and specificity. Based on the validation results, the laboratory prototype of the real-time Polymerase chain reaction kit for detecting the rs1495741 polymorphic site in the human N-acetyltransferase 2 gene associated with xenobiotic acetylation can be recommended for use in human genetic studies
- 10 March 2026
- Published by Irkutsk State Medical University in Baikal Medical Journal
- Vol. 5 (1) , 72-79
Open AccessVALIDATION OF A REAL-TIME PCR ASSAY FOR THE DETECTION OF THE SINGLE NUCLEOTIDE POLYMORPHISM RS1495741 IN THE HUMAN NAT2 GENE ASSOCIATED WITH XENOBIOTIC ACETYLATION
Relevance. According to polymorphisms in the N-acetyltransferase 2 gene, two main acetylation types are distinguished: rapid and slow. The frequency of adverse drug reactions varies depending on the rate of metabolism. In particular, the incidence of neuro- and hepatotoxic effects of isoniazid is associated with genotype, with slow acetylators having a higher risk of adverse reactions. Aim: To design and compare a reagent kit developed by the authors for detecting polymorphisms in the human N-acetyltransferase 2 gene using real-time Polymerase chain reaction, aimed at determining the type of xenobiotic acetylation in humans. Materials and Methods. Based on Eurasian Patent No. 042541, a laboratory prototype of a medical diagnostic reagent kit was developed. The kit included a real-time Polymerase chain reaction mixture, forward and reverse primers specific to the N-acetyltransferase 2 gene, and probes for detecting the rs1495741 polymorphism labeled with FAM and R6G fluorophores at the 5'-end and BHQ2 RTQ1 quenchers with closed nucleotides. Positive controls were constructed as circular plasmids pJet1.2/blunt containing the N-acetyltransferase 2 gene with rs1495741A and rs1495741G alleles. Using the developed kit, 37 Deoxyribonucleic acid samples obtained from healthy individuals were analyzed and compared with the reference method. Analytical sensitivity, diagnostic sensitivity, diagnostic specificity, precision, and reproducibility were assessed to validate the method. Results. Validation of the reagent kit for real-time Polymerase chain reaction determination of the xenobiotic acetylation type in humans was performed. The analytical sensitivity of the test, determined by titration of the positive control, was 0.1 ng/µL Deoxyribonucleic acid; diagnostic sensitivity was 0.94, and diagnostic specificity was 1. Other validation parameters met the established acceptability criteria, confirming adequate intra-laboratory precision and inter-laboratory reproducibility. Conclusion. Compared with the reference method, the proposed approach is less labor-intensive, time-saving, and more cost-effective, while maintaining comparable sensitivity and specificity. Based on the validation results, the laboratory prototype of the real-time Polymerase chain reaction kit for detecting the rs1495741 polymorphic site in the human N-acetyltransferase 2 gene associated with xenobiotic acetylation can be recommended for use in human genetic studies
- Open Access
- 26 December 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (6) , 188-198
Molecular genetic structure of Mycobacterium tuberculosis in Krasnoyarsk region
Introduction. Despite the improvement of the general epidemiological situation for tuberculosis (TB) in Krasnoyarsk region, the spread of multiple and pre-extensive drug resistance (MDR and pre-XDR) of the pathogen remains a serious problem that requires a comprehensive analysis of factors, including an assessment of the circulating population of Mycobacterium tuberculosis. Objective. T o assess the molecular genetic structure of M. tuberculosis strains in Krasnoyarsk region. Materials and methods. A total of 400 strains were studied for 2024 using SNPand MIRU-VNTR-24 typing. Results. High levels of MDR (64.5 %), including pre-XDR (45.0 %) and XDR (1.5 %), were detected in the sample of M. tuberculosis strains. The dominance of L2 (Beijing genotype) was found in newly diagnosed cases (72.1 %) and previously treated patients (85.6 %). Non-Beijing strains belonged to the L4 genotypes (LAM, Ural, Haarlem and S). The most common Beijing subtypes were B0/W148 (49.5 %; 198/400) and Central Asian Russian (25.0 %; 99/400), they differed significantly in MDR levels (96.5 % and 36.4 %, respectively, by subtype; p < 0.001). Beijing B0/W148 strains had the highest levels of preXDR (71.7 %) and XDR (3.0 %). MDR among L4 strains (30.1 %) was significantly lower compared to Beijing (76.4 %) (p < 0.001). Strains from HIV-TB patients were more common with an MDR profile (74.4 %) than from patients without HIV infection (60.4 %) (p = 0.008) against the background of a higher presence of Beijing B0/W148 in the HIVTB group (59.8 % versus 45.2 %; p = 0.008). Conclusion. Beijing B0/W148 strains account for about half of the study sample and make a significant contribution to the pre-XDR (78.9 %) and XDR (100 %), which requires further monitoring and enhanced control of treatment effectiveness.
- 26 December 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (6) , 188-198
Open AccessMolecular genetic structure of Mycobacterium tuberculosis in Krasnoyarsk region
Introduction. Despite the improvement of the general epidemiological situation for tuberculosis (TB) in Krasnoyarsk region, the spread of multiple and pre-extensive drug resistance (MDR and pre-XDR) of the pathogen remains a serious problem that requires a comprehensive analysis of factors, including an assessment of the circulating population of Mycobacterium tuberculosis. Objective. T o assess the molecular genetic structure of M. tuberculosis strains in Krasnoyarsk region. Materials and methods. A total of 400 strains were studied for 2024 using SNPand MIRU-VNTR-24 typing. Results. High levels of MDR (64.5 %), including pre-XDR (45.0 %) and XDR (1.5 %), were detected in the sample of M. tuberculosis strains. The dominance of L2 (Beijing genotype) was found in newly diagnosed cases (72.1 %) and previously treated patients (85.6 %). Non-Beijing strains belonged to the L4 genotypes (LAM, Ural, Haarlem and S). The most common Beijing subtypes were B0/W148 (49.5 %; 198/400) and Central Asian Russian (25.0 %; 99/400), they differed significantly in MDR levels (96.5 % and 36.4 %, respectively, by subtype; p < 0.001). Beijing B0/W148 strains had the highest levels of preXDR (71.7 %) and XDR (3.0 %). MDR among L4 strains (30.1 %) was significantly lower compared to Beijing (76.4 %) (p < 0.001). Strains from HIV-TB patients were more common with an MDR profile (74.4 %) than from patients without HIV infection (60.4 %) (p = 0.008) against the background of a higher presence of Beijing B0/W148 in the HIVTB group (59.8 % versus 45.2 %; p = 0.008). Conclusion. Beijing B0/W148 strains account for about half of the study sample and make a significant contribution to the pre-XDR (78.9 %) and XDR (100 %), which requires further monitoring and enhanced control of treatment effectiveness.
- Open Access
- 15 July 2025
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 102 (3) , 343-349
Whole-genome sequencing of two clinical strains of Mycobacterium tuberculosis with phenotypic susceptibility to rifampicin but predicted resistance by Xpert MTB/RIF
Introduction. More than 40% of Mycobacterium tuberculosis strains are resistant to rifampicin (RIF) and isoniazid, the first-line drugs. The tuberculosis pathogen becomes resistant to RIF mainly due to mutations in the rpoB gene. The aim of the study was to search for the most probable compensatory mutations in the rpoA, rpoB and rpoC genes encoding α-, β- and β′-subunits of M. tuberculosis RNA polymerase. Materials and methods. A cross-sectional analysis of phenotypic and genetic resistance to RIF among 2298 clinical strains of M. tuberculosis revealed 8 cases in which resistance as determined by the Xpert Ultra MTB/RIF test was not confirmed bacteriologically. In all cases, these were chronic multidrug-resistant or extensively drug-resistant M. tuberculosis patients in whom RIF was discontinued due to the detection of resistance to this drug in the isolated strains. Two strains were obtained for genotype testing, Sanger sequencing and whole-genome sequencing. Results. Repeat Xpert Ultra MTB/RIF test, Sanger sequencing and whole genome sequencing revealed the presence of a single S450L mutation in the rpoB gene with phenotypic sensitivity in both strains. Phylogenetic analysis revealed that both genomes belonged to the Beijing B0/W148 genotype. The strains were characterized by a higher growth rate than the other isolates. Two potential compensatory mutations V483G and H748P in the groC gene were identified in the absence of other significant changes in the rpoA and rpoB genes. Conclusion. It is suggested that the phenomenon of discrepancy between results of bacteriological and molecular genetic tests is associated with the acquisition of compensatory mutations in the groC gene during RIF treatment of Beijing B0/W148 strains, and the identified mutations affect the conformation of the β'-subunit, restoring the transcription efficiency of affected by the major S450L mutation.
- 15 July 2025
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 102 (3) , 343-349
Open AccessWhole-genome sequencing of two clinical strains of Mycobacterium tuberculosis with phenotypic susceptibility to rifampicin but predicted resistance by Xpert MTB/RIF
Introduction. More than 40% of Mycobacterium tuberculosis strains are resistant to rifampicin (RIF) and isoniazid, the first-line drugs. The tuberculosis pathogen becomes resistant to RIF mainly due to mutations in the rpoB gene. The aim of the study was to search for the most probable compensatory mutations in the rpoA, rpoB and rpoC genes encoding α-, β- and β′-subunits of M. tuberculosis RNA polymerase. Materials and methods. A cross-sectional analysis of phenotypic and genetic resistance to RIF among 2298 clinical strains of M. tuberculosis revealed 8 cases in which resistance as determined by the Xpert Ultra MTB/RIF test was not confirmed bacteriologically. In all cases, these were chronic multidrug-resistant or extensively drug-resistant M. tuberculosis patients in whom RIF was discontinued due to the detection of resistance to this drug in the isolated strains. Two strains were obtained for genotype testing, Sanger sequencing and whole-genome sequencing. Results. Repeat Xpert Ultra MTB/RIF test, Sanger sequencing and whole genome sequencing revealed the presence of a single S450L mutation in the rpoB gene with phenotypic sensitivity in both strains. Phylogenetic analysis revealed that both genomes belonged to the Beijing B0/W148 genotype. The strains were characterized by a higher growth rate than the other isolates. Two potential compensatory mutations V483G and H748P in the groC gene were identified in the absence of other significant changes in the rpoA and rpoB genes. Conclusion. It is suggested that the phenomenon of discrepancy between results of bacteriological and molecular genetic tests is associated with the acquisition of compensatory mutations in the groC gene during RIF treatment of Beijing B0/W148 strains, and the identified mutations affect the conformation of the β'-subunit, restoring the transcription efficiency of affected by the major S450L mutation.
- Open Access
- 19 May 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (2) , 239-248
Changes in the molecular genetic structure of Mycobacterium tuberculosis in Republic Sakha (Yakutia) in 2009–2024: spread of Beijing B0/W148 subtype
Introduction. In the Republic of Sakha (Yakutia) since 2020, the incidence of tuberculosis (TB) has become lower than the Russian average against the background of an increase in the proportion of multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, including among new cases.Objective. To analyze the changes in the molecular genetic structure of M. tuberculosis strains for 2009–2024.Materials and methods. We studied 669 strains for 2009–2014 (first period) and 2022– 2024 (second period) by RD 207/105/181, SNPand MIRU-VNTR 24 typing methods.Results. The primary MDR (without pre-XDR and XDR) were 22.2 % and 24.6 % by periods, the pre-XDR increased from 1.0 % to 16.9 % and XDR strains were emergence in 3.3 % in 2022–2024. In the second period, the Beijing genotype was predominance (67.3 % vs. 43.3 % in the first period; p < 0.001), Beijing Central Asian Russian was increased from 21.7 % to 31.0 % (p = 0.006), Beijing B0/W148 was increased from 14.9 to 34.0 % (p < 0.001). Euro-American lineage was represented by endemic for Sakha (Yakutia) S genotype (13.8 % and 18.0 % by periods), genotypes T, LAM, Ural, H. In all age groups in the second period, an increase in the proportion of Beijing B0/W148 was found. The pre-XDR profiles of B0/W148 were increased (53,9 % vs 7,3 %; p < 0,001) and was found XDR (6.9 %). For genotype S, the primary pre-XDR (33,3 % vs 5,7 %; p = 0,002) was increased and XDR was found in 44.4 %.Conclusion. In the period of 2022–2024, in the M. tuberculosis population, a high level of pre-XDR and XDR in Beijing B0/W148 strains (60.8 %), and S genotype (60.1 %) was detected. Beijing B0/W148 strains have spread and influence MDR amplification, as the endemic S genotype, which requires further surveillance and control.
- 19 May 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (2) , 239-248
Open AccessChanges in the molecular genetic structure of Mycobacterium tuberculosis in Republic Sakha (Yakutia) in 2009–2024: spread of Beijing B0/W148 subtype
Introduction. In the Republic of Sakha (Yakutia) since 2020, the incidence of tuberculosis (TB) has become lower than the Russian average against the background of an increase in the proportion of multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, including among new cases.Objective. To analyze the changes in the molecular genetic structure of M. tuberculosis strains for 2009–2024.Materials and methods. We studied 669 strains for 2009–2014 (first period) and 2022– 2024 (second period) by RD 207/105/181, SNPand MIRU-VNTR 24 typing methods.Results. The primary MDR (without pre-XDR and XDR) were 22.2 % and 24.6 % by periods, the pre-XDR increased from 1.0 % to 16.9 % and XDR strains were emergence in 3.3 % in 2022–2024. In the second period, the Beijing genotype was predominance (67.3 % vs. 43.3 % in the first period; p < 0.001), Beijing Central Asian Russian was increased from 21.7 % to 31.0 % (p = 0.006), Beijing B0/W148 was increased from 14.9 to 34.0 % (p < 0.001). Euro-American lineage was represented by endemic for Sakha (Yakutia) S genotype (13.8 % and 18.0 % by periods), genotypes T, LAM, Ural, H. In all age groups in the second period, an increase in the proportion of Beijing B0/W148 was found. The pre-XDR profiles of B0/W148 were increased (53,9 % vs 7,3 %; p < 0,001) and was found XDR (6.9 %). For genotype S, the primary pre-XDR (33,3 % vs 5,7 %; p = 0,002) was increased and XDR was found in 44.4 %.Conclusion. In the period of 2022–2024, in the M. tuberculosis population, a high level of pre-XDR and XDR in Beijing B0/W148 strains (60.8 %), and S genotype (60.1 %) was detected. Beijing B0/W148 strains have spread and influence MDR amplification, as the endemic S genotype, which requires further surveillance and control.
- Open Access
- 18 November 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 101 (5) , 628-640
Circulation of Mycobacterium tuberculosis strains of the Beijing Central Asian Outbreak genotype in the Kemerovo region — Kuzbass in 2018–2022
Introduction. The Kemerovo region — Kuzbass is characterized by a high prevalence of multidrug-resistant (MDR) tuberculosis (TB), including coinfection with HIV (HIV/TB). A previously unknown in Russia relationship between MDR and the Beijing Central Asian Outbreak (CAO) subtype has been discovered, which updates studies of Mycobacterium tuberculosis taking into account this resistant variant. Objective: to study the molecular genetic structure of the M. tuberculosis population, to assess the prevalence and possible routes of emergence of Beijing CAO strains in the Kemerovo region — Kuzbass. Materials and methods. A total of 325 M. tuberculosis strains were studied in 2018–2022 using spoligotyping, MIRU-VNTR 24 and SNP typing. Whole genome sequencing and bioinformatics analysis were performed for seven Beijing CAO strains. Results. Primary MDR and pre-extensive drug resistance (pre-XDR) were detected in 39.4% and 11.5% of strains, respectively. In the total sample, MDR was 43.4%, pre-XDR — 19.7%. In the structure of the M. tuberculosis population, the Beijing genotype prevailed (78.8%), with its subtypes Central Asian Russian (40.9%) and B0/W148 (32.6%). The Euro-American lineage (27.3%) was represented by the genotypes T (6.5%), LAM (5.8%), Ural (4.9%), H (0.9%); one strain CAS1-Delhi was detected, the genotype of 2.8% of strains was not identified. The proportion of Beijing CAO was 12.6% of the total sample; this subtype was significantly more often detected among HIV/TB (20.6%) than in HIV-negative TB patients (9.1%; p = 0.005). The results of the Beijing CAO genome analysis from the Kemerovo region indicate the absence of a direct chain of transmission between these TB cases. A hypothesis has been put forward about the introduction of Beijing CAO to the Kemerovo region from Central Asia and its endemic circulation in the region. Conclusion. A high level of MDR and pre-XDR was detected in Beijing genotype strains in the M. tuberculosis population of the Kemerovo region — Kuzbass, especially the B0/W148 (97.2%) and CAO (87.5%) subtypes. Beijing CAO strains, detected mainly in newly diagnosed HIV/TB patients, require further monitoring and control of their spreading.
- 18 November 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 101 (5) , 628-640
Open AccessCirculation of Mycobacterium tuberculosis strains of the Beijing Central Asian Outbreak genotype in the Kemerovo region — Kuzbass in 2018–2022
Introduction. The Kemerovo region — Kuzbass is characterized by a high prevalence of multidrug-resistant (MDR) tuberculosis (TB), including coinfection with HIV (HIV/TB). A previously unknown in Russia relationship between MDR and the Beijing Central Asian Outbreak (CAO) subtype has been discovered, which updates studies of Mycobacterium tuberculosis taking into account this resistant variant. Objective: to study the molecular genetic structure of the M. tuberculosis population, to assess the prevalence and possible routes of emergence of Beijing CAO strains in the Kemerovo region — Kuzbass. Materials and methods. A total of 325 M. tuberculosis strains were studied in 2018–2022 using spoligotyping, MIRU-VNTR 24 and SNP typing. Whole genome sequencing and bioinformatics analysis were performed for seven Beijing CAO strains. Results. Primary MDR and pre-extensive drug resistance (pre-XDR) were detected in 39.4% and 11.5% of strains, respectively. In the total sample, MDR was 43.4%, pre-XDR — 19.7%. In the structure of the M. tuberculosis population, the Beijing genotype prevailed (78.8%), with its subtypes Central Asian Russian (40.9%) and B0/W148 (32.6%). The Euro-American lineage (27.3%) was represented by the genotypes T (6.5%), LAM (5.8%), Ural (4.9%), H (0.9%); one strain CAS1-Delhi was detected, the genotype of 2.8% of strains was not identified. The proportion of Beijing CAO was 12.6% of the total sample; this subtype was significantly more often detected among HIV/TB (20.6%) than in HIV-negative TB patients (9.1%; p = 0.005). The results of the Beijing CAO genome analysis from the Kemerovo region indicate the absence of a direct chain of transmission between these TB cases. A hypothesis has been put forward about the introduction of Beijing CAO to the Kemerovo region from Central Asia and its endemic circulation in the region. Conclusion. A high level of MDR and pre-XDR was detected in Beijing genotype strains in the M. tuberculosis population of the Kemerovo region — Kuzbass, especially the B0/W148 (97.2%) and CAO (87.5%) subtypes. Beijing CAO strains, detected mainly in newly diagnosed HIV/TB patients, require further monitoring and control of their spreading.
- Open Access
- 28 September 2024
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 9 (4) , 237-247
Beijing Central Asian Outbreak strain cluster of Mycobacterium tuberculosis detected in Irkutsk region, Russia
Background. Irkutsk region maintains a high incidence rate of multidrug-resistant (MDR) tuberculosis (TB). Detection of MDR-associated Mycobacterium tuberculosis strains in Irkutsk region requires dynamic assessment of the TB pathogen population, taking into account the emergence of a new resistant variant of Beijing Central Asian Outbreak (CAO).The aim of the study. To assess changes in the genotypic structure of M. tuberculosis strains circulating in the Irkutsk region over a ten-year period.Materials and methods. A total of 732 M. tuberculosis strains (196 strains for 2021– 2022, 536 strains for 2011–2015) were studied using MIRU-VNTR and SNP typing.Results. The MDR level increased to 67.4 % with an increase of pre-extensive drug resistance (pre-XDR) (33.2 %) (p < 0.001). In the modern sample, the dominance of the Beijing genotype increased (83.7 %) due to an increase in the proportions of the B0/W148 (38.8 %) and CAO (12.8 %) subtypes with a stable overall level of Central Asian Russian (36.8 %) and other Beijing strains (8.2 %). Strains other than the Beijing genotype belonged mainly to the Euro-American lineage (Lineage 4): LAM (8.9 %), Ural (2.7 %), Haarlem (2.0 %), S (0.5 %) and L4-unclassified (5.3 %); 25 isolates were not classified. In the 2011–2015 sample, LAM was more common than in the modern sample (10.8 % vs. 3.6 %; p < 0.01). The increase in MDR and preXDR was statistically significant among Beijing B0/W148 strains (93.4 % vs. 66.1 %; p < 0.001).Conclusion. Unfavorable trends of significant spread of MDR and pre-XDR of the Beijing genotype strains were revealed. Among the Beijing strains, not only B0/W148 but also the Beijing CAO subtype, which was previously rare in Siberia, are the most successful; they have the highest levels of MDR and pre-XDR and a tendency to widespread distribution in all groups of TB patients.
- 28 September 2024
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 9 (4) , 237-247
Open AccessBeijing Central Asian Outbreak strain cluster of Mycobacterium tuberculosis detected in Irkutsk region, Russia
Background. Irkutsk region maintains a high incidence rate of multidrug-resistant (MDR) tuberculosis (TB). Detection of MDR-associated Mycobacterium tuberculosis strains in Irkutsk region requires dynamic assessment of the TB pathogen population, taking into account the emergence of a new resistant variant of Beijing Central Asian Outbreak (CAO).The aim of the study. To assess changes in the genotypic structure of M. tuberculosis strains circulating in the Irkutsk region over a ten-year period.Materials and methods. A total of 732 M. tuberculosis strains (196 strains for 2021– 2022, 536 strains for 2011–2015) were studied using MIRU-VNTR and SNP typing.Results. The MDR level increased to 67.4 % with an increase of pre-extensive drug resistance (pre-XDR) (33.2 %) (p < 0.001). In the modern sample, the dominance of the Beijing genotype increased (83.7 %) due to an increase in the proportions of the B0/W148 (38.8 %) and CAO (12.8 %) subtypes with a stable overall level of Central Asian Russian (36.8 %) and other Beijing strains (8.2 %). Strains other than the Beijing genotype belonged mainly to the Euro-American lineage (Lineage 4): LAM (8.9 %), Ural (2.7 %), Haarlem (2.0 %), S (0.5 %) and L4-unclassified (5.3 %); 25 isolates were not classified. In the 2011–2015 sample, LAM was more common than in the modern sample (10.8 % vs. 3.6 %; p < 0.01). The increase in MDR and preXDR was statistically significant among Beijing B0/W148 strains (93.4 % vs. 66.1 %; p < 0.001).Conclusion. Unfavorable trends of significant spread of MDR and pre-XDR of the Beijing genotype strains were revealed. Among the Beijing strains, not only B0/W148 but also the Beijing CAO subtype, which was previously rare in Siberia, are the most successful; they have the highest levels of MDR and pre-XDR and a tendency to widespread distribution in all groups of TB patients.
- Open Access
- 15 January 2024
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 8 (6) , 124-129
Online service for interpretation of the resistance prediction results to bedaquiline by the molecular data
Background. Bedaquiline is a new and promising anti-tuberculosis drug, but longterm use requires resistance. This is due to mutations in the atpE and mmpR genes in M. tuberculosis (MBT).The aim of the research was to test a system for automated interpretation of results for predicting resistance to bedaquiline by the molecular data.Materials and methods. DNA was isolated from strains of M. tuberculosis in the Irkutsk region and Yakutia. The total quantity of DNA samples was 27 strains from Yakutia and 21 strains from the Irkutsk region. The study of MBT genomes was carried out on the DNA previously obtained by the authors in the territories of the Irkutsk region (n = 5), Yakutia (n = 4), Buryatia (n = 3), Zabaykalskiy kray (n = 4) and the Far East (n = 8). We used the BSATool program to detect bedaquiline resistance based on Sanger and genomic data. Sanger sequencing analyzed the atpE and mmpR genes, and whole genome sequencing examined mutations in the same sequences, as well as additionally in mmpL5, mmpS5, Rv0678, Rv1979c, and pepQ.Results. Complete agreement between the phenotypic and genotypic analysis of resistance to bedaquiline was found for three strains from Yakutia. One genome with significant mutations to bedaquiline was identified. A conclusion was made about the importance of molecular analysis of target genes with subsequent detection of resistance to bedaquiline in silico.
- 15 January 2024
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 8 (6) , 124-129
Open AccessOnline service for interpretation of the resistance prediction results to bedaquiline by the molecular data
Background. Bedaquiline is a new and promising anti-tuberculosis drug, but longterm use requires resistance. This is due to mutations in the atpE and mmpR genes in M. tuberculosis (MBT).The aim of the research was to test a system for automated interpretation of results for predicting resistance to bedaquiline by the molecular data.Materials and methods. DNA was isolated from strains of M. tuberculosis in the Irkutsk region and Yakutia. The total quantity of DNA samples was 27 strains from Yakutia and 21 strains from the Irkutsk region. The study of MBT genomes was carried out on the DNA previously obtained by the authors in the territories of the Irkutsk region (n = 5), Yakutia (n = 4), Buryatia (n = 3), Zabaykalskiy kray (n = 4) and the Far East (n = 8). We used the BSATool program to detect bedaquiline resistance based on Sanger and genomic data. Sanger sequencing analyzed the atpE and mmpR genes, and whole genome sequencing examined mutations in the same sequences, as well as additionally in mmpL5, mmpS5, Rv0678, Rv1979c, and pepQ.Results. Complete agreement between the phenotypic and genotypic analysis of resistance to bedaquiline was found for three strains from Yakutia. One genome with significant mutations to bedaquiline was identified. A conclusion was made about the importance of molecular analysis of target genes with subsequent detection of resistance to bedaquiline in silico.
- Open Access
- 4 January 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 100 (6) , 428-441
Genetic structure and drug resistance of Mycobacterium tuberculosis strains in the Kemerovo Region — Kuzbass
Background. Kemerovo Region has a high burden of tuberculosis (TB) with incidence rates twice the national average. The circulating variants of Mycobacterium tuberculosis significantly influence the TB epidemic process. Screening of epidemically significant variants of the pathogen in areas with a high burden of TB underlies epidemiological diagnosis and is necessary for the development of effective prevention measures. However, the population structure of M. tuberculosis in the Kemerovo Region — Kuzbass is poorly understood. Aims: to study genetic heterogeneity and phenotypic resistance to anti-tuberculosis drugs of M. tuberculosis strains in the Kemerovo Region. Materials and methods. The MIRU-VNTR genotyping of 163 M. tuberculosis strains isolated from TB patients in the Kemerovo Region in March–October 2022 was carried out. Cultivation of M. tuberculosis, drug susceptibility testing, and isolation of genomic DNA were carried out by standard methods. Genotypic identification was performed using MIRU-VNTR (24 loci) typing. In parallel, express genotyping was carried out: identification of isolates of the Beijing genotype (by RD105/207) and non-Beijing; subtyping Beijing using real-time PCR tests for detection of Central Asian Russian and B0/W148; identification of the non-Beijing group by real-tine PCR RT tests for LAM, S, Ural. Results. The isolates of the Beijing genotype (67.5%) were found to dominate both among newly diagnosed (64.4%) and previously treated patients (88.5%). MIRU-VNTR typing revealed 75 profiles, of which 94-32 (35.3%) and 100-32 (15.7%) were the most abundant and belonged to the Beijing genotype. Overall, 39.9% and 20.9% of isolates, respectively, were assigned to the Beijing Central Asian Russian and B0/W148 epidemic clusters, which differed significantly in MDR levels (50.8% and 85.3%, respectively; p = 0.005). The second most common were strains of the genetic family of the Euro-American lineage (L4) (31.9%): LAM (6.7%) Ural (7.4%) Haarlem (4.9%) and L4-unclassified (12.9%), MDR among of these minor genotypes was significantly lower than among Beijing genotype strains, and amounted to 11.5% (p 0.001). Strains from HIV-TB patients (56.4% of the total sample) carried an MDR profile more often (54.8%) compared to TB cases without HIV infection (35.2%) (p = 0.005), which may be due to higher proportion of Beijing genotype strains in the HIV-TB group (75.0% vs. 57.7%; p = 0.026). Complete comparability of the SNP analysis (in-house tests) to identify the main genotypes and epidemically significant Beijing subtypes was shown, which made it possible to characterize 75.5% of the sample by the express method. Conclusions. The molecular genetic screening carried out in the Kemerovo Region revealed the heterogeneity of the M. tuberculosis population, which was dominated by strains of the Beijing genotype, with the frequency of subtypes comparable with other territories of the Siberian Federal District.
- 4 January 2024
- Published by Central Research Institute for Epidemiology in Journal of microbiology, epidemiology and immunobiology
- Vol. 100 (6) , 428-441
Open AccessGenetic structure and drug resistance of Mycobacterium tuberculosis strains in the Kemerovo Region — Kuzbass
Background. Kemerovo Region has a high burden of tuberculosis (TB) with incidence rates twice the national average. The circulating variants of Mycobacterium tuberculosis significantly influence the TB epidemic process. Screening of epidemically significant variants of the pathogen in areas with a high burden of TB underlies epidemiological diagnosis and is necessary for the development of effective prevention measures. However, the population structure of M. tuberculosis in the Kemerovo Region — Kuzbass is poorly understood. Aims: to study genetic heterogeneity and phenotypic resistance to anti-tuberculosis drugs of M. tuberculosis strains in the Kemerovo Region. Materials and methods. The MIRU-VNTR genotyping of 163 M. tuberculosis strains isolated from TB patients in the Kemerovo Region in March–October 2022 was carried out. Cultivation of M. tuberculosis, drug susceptibility testing, and isolation of genomic DNA were carried out by standard methods. Genotypic identification was performed using MIRU-VNTR (24 loci) typing. In parallel, express genotyping was carried out: identification of isolates of the Beijing genotype (by RD105/207) and non-Beijing; subtyping Beijing using real-time PCR tests for detection of Central Asian Russian and B0/W148; identification of the non-Beijing group by real-tine PCR RT tests for LAM, S, Ural. Results. The isolates of the Beijing genotype (67.5%) were found to dominate both among newly diagnosed (64.4%) and previously treated patients (88.5%). MIRU-VNTR typing revealed 75 profiles, of which 94-32 (35.3%) and 100-32 (15.7%) were the most abundant and belonged to the Beijing genotype. Overall, 39.9% and 20.9% of isolates, respectively, were assigned to the Beijing Central Asian Russian and B0/W148 epidemic clusters, which differed significantly in MDR levels (50.8% and 85.3%, respectively; p = 0.005). The second most common were strains of the genetic family of the Euro-American lineage (L4) (31.9%): LAM (6.7%) Ural (7.4%) Haarlem (4.9%) and L4-unclassified (12.9%), MDR among of these minor genotypes was significantly lower than among Beijing genotype strains, and amounted to 11.5% (p 0.001). Strains from HIV-TB patients (56.4% of the total sample) carried an MDR profile more often (54.8%) compared to TB cases without HIV infection (35.2%) (p = 0.005), which may be due to higher proportion of Beijing genotype strains in the HIV-TB group (75.0% vs. 57.7%; p = 0.026). Complete comparability of the SNP analysis (in-house tests) to identify the main genotypes and epidemically significant Beijing subtypes was shown, which made it possible to characterize 75.5% of the sample by the express method. Conclusions. The molecular genetic screening carried out in the Kemerovo Region revealed the heterogeneity of the M. tuberculosis population, which was dominated by strains of the Beijing genotype, with the frequency of subtypes comparable with other territories of the Siberian Federal District.